tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
US Market
TAK
Takeda Pharmaceutical Company
RESEARCH TOOLSreports
Want to see TAK full AI Analyst Report?

Takeda Pharmaceutical Company (TAK) Financial Statements

1,348 Followers

Takeda Pharmaceutical Company Financial Overview

Takeda Pharmaceutical Company's market cap is currently $56.45B. The company's EPS TTM is $0.213; its P/E ratio is 18.30; and it has a dividend yield of 3.86%. Takeda Pharmaceutical Company is scheduled to report earnings on January 29, 2026, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit¥ 3.00T¥ 2.83T¥ 2.78T¥ 2.46T¥ 2.20T
Operating Income¥ 342.59B¥ 214.07B¥ 490.50B¥ 460.84B¥ 509.27B
EBITDA¥ 1.21T¥ 1.14T¥ 1.28T¥ 1.18T¥ 983.72B
Net Income¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Balance Sheet
Cash & Short-Term Investments¥ 405.59B¥ 472.89B¥ 553.70B¥ 875.00B¥ 1.00T
Total Assets¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T¥ 12.91T
Total Debt¥ 4.52T¥ 4.84T¥ 4.38T¥ 4.35T¥ 4.64T
Net Debt¥ 4.13T¥ 4.39T¥ 3.85T¥ 3.50T¥ 3.67T
Total Liabilities¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T¥ 7.74T
Stockholders' Equity¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T¥ 5.17T
Cash Flow
Free Cash Flow¥ 856.39B¥ 235.61B¥ 343.47B¥ 937.07B¥ 774.46B
Operating Cash Flow¥ 1.06T¥ 716.34B¥ 977.16B¥ 1.12T¥ 1.01T
Investing Cash Flow¥ -367.06B¥ -463.86B¥ -607.10B¥ -198.13B¥ 393.53B
Financing Cash Flow¥ -751.42B¥ -354.42B¥ -709.15B¥ -1.07T¥ -1.09T
Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History

Income Statement >

Takeda Pharmaceutical Company Debt to Assets

Balance Sheet >

Takeda Pharmaceutical Company Cash Flow

Cash Flow >

Takeda Pharmaceutical Company Forecast EPS vs Actual EPS

Earnings >